Chularat Hospital Public Company Limited (CHG)
Thailand Exchange · Thailand · prices in THB · close of 22 Oct 2026
Key indicators
| Last close | THB 1.530 |
|---|---|
| 52-week range | 1.330 – 1.780 |
| Return, 1 month / 3 months | −4.4% / +2.0% |
| Return, 1 year / 3 years | +3.6% / −46.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 32.4% |
| Worst drawdown (1 year) | -22.7% |
| Average daily value traded | 71.48M THB |
| Dividend yield | 4.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Chularat Hospital Public Company Limited runs private hospitals in Thailand, serving patients in the Bangkok area and nearby eastern provinces. The company offers general medical care along with specialised services through its hospital branches, treating local residents and paying patients who seek private treatment. Its facilities provide outpatient and inpatient care, and the group also operates related healthcare services that support its hospital network.
On this site Chularat Hospital Public Company Limited appears as a stock on the Thailand Exchange (Thailand), code CHG, with prices in Thai baht (THB). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Chularat Hospital Public Company Limited (CHG) trades on the Thailand Exchange in Thailand. It last closed at THB 1.530 on 22 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 397 of 1,349 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.6% and over the last three months it rose 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Thailand Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.1% | ||
| From 52-week high | -13.1% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.0% | ||
| 6-month return | 13.9% | ||
| 12-month return, skipping the last month | 8.4% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.7% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 71.48M THB | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.2% |
|---|---|
| 1 month | −4.4% |
| 3 months | +2.0% |
| 6 months | +13.9% |
| 1 year | +3.6% |
| 3 years | −46.4% |
| 5 years | −49.8% |
Signals
| 50-day / 200-day average | 1.559 / 1.484 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.042 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Aug 2026 | THB 0.0200 |
| 6 May 2026 | THB 0.0500 |
| 27 Aug 2025 | THB 0.0200 |
| 6 May 2025 | THB 0.0500 |
| 27 Aug 2024 | THB 0.0200 |
| 3 May 2024 | THB 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Thailand Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.